Dr Iman Azimi, School of Pharmacy and Pharmacology, University of Tasmania


Dr Azimi obtained his PhD in 2011 from the Lowy Cancer Research Centre at the University of New South Wales. He then joined The University of Queensland School of Pharmacy as a postdoctoral researcher from 2011 to 2017. During his time at UQ he worked on multiple projects of both basic science and industry natures in cancer research. Dr Azimi then joined the University of Tasmania in 2018 to take on a role as a lecturer and coordinator in Pharmaceutical Science, and to establish his independent research group. During this time at the UTAS School of Pharmacy and Pharmacology, his research focused on identifying potential therapeutic targets in brain cancers and ageing, with the focus on targeting calcium signalling and metabolic pathways. In addition to his role at UTAS, Iman also acts as the Chair of Institutional Biosafety Committee of Novotech CRO.

About Seminar Series

The School of Pharmacy Seminar Series involves regular formal presentations of high-quality scholarly work with broad appeal.

The wider School community is invited to attend, including academic and professional staff, special guests, visitors, as well as HDR, postgraduate, masters and honours students.


Level 5, Pharmacy Australia Centre of Excellence (PACE) 20 Cornwall Street, Woolloongabba 4102
Online, or Room 5034